[1] Paradowska-Stolarz A,Dubowik M,et al.Dental anomalies in the incisor-canine region in patients with cleft lip and palate - literature review. Dev Period Med. 2014;18(1):66-69.
[2] 黄迪炎,陈海龙.先天性唇腭裂治疗现状[J].实用医药杂志,2003, 20(1):68-70.
[3] 毛萌,朱军.出生缺陷监测研究现状[J].实用儿科临床杂志,2009, 24(11):801-803.
[4] Cho-Lee GY, García-Díez EM, Nunes RA,et al.Review of secondary alveolar cleft repair.Ann Maxillofac Surg.2013;3(1): 46-50.
[5] Gimbel M,Ashley RK,Sisodia M,et al.Repair of alveolar cleft defects: reduced morbidity with bone marrow stem cells in a resorbable matrix. J CraniofacSurg. 2007;18(4):895-901.
[6] Park SH, Park DS, Shin JW, et al.Scaffolds for bone tissue engineering fabricated from two different materials by the rapid prototyping technique: PCL versus PLGA.J Mater Sci Mater Med.2012;23(11):2671-2678.
[7] Gopferich A. Mechanisms of polymer degradation and erosion. Biomaterials. 1996;17:103-114.
[8] Grayson AC,Voskerician G,Lynn A,et al. Differential degradation rates in vivo and in vitro of biocompatible poly(lactic acid) and poly(glycolic acid)homo- and co-polymers for a polymeric drug-delivery microchip.J Biomater Sci Polym Ed. 2004;15(10):1281-1304.
[9] Pan Z,Ding JD.Poly(lactide-co-glycolide) porous scaffolds for tissue engineering and regenerative medicine.Interface Focus. 2012;2(3):366-377.
[10] Middleton JC,Tipton AJ.Synthetic biodegradable polymers as orthopaedic devices. Biomaterials.2000;21:2335-2346.
[11] Yang S,Leong KF,Du Z,et al.The design of scaffolds for use in tissue engineering. Part I. Traditional factors.Tissue Eng. 2001; 7:679-689.
[12] Iroh JO. Poly(epsilon-caprolactone). In: Mark JE, editor. Polymer data handbook. Oxford: Oxford Press; 1999:361-362.
[13] Mark JE. Polymerdata handbook. Oxford: Oxford Press,1999: 527-633.
[14] Ramakrishna S,Huang ZM,Kumar GV,et al. An introduction to biocomposites. London: Imperial College Press,2004:36.
[15] Seal BL,Otero TC,Panitch A.Polymeric biomaterials for tissue and organ regeneration. Mater Sci Eng R Rep.2001;34: 147-230.
[16] Athanasiou KA,Schmitz JP,Agrawal CM.The effects of porosity on in vitro degradation of polylactic acid polyglycolic acid implants used in repair of articular cartilage.Tissue Eng. 1998;4:53-63.
[17] Agrawal CM,McKinney JS,Lanctot D,et al.Effects of fluid flow on the in vitro degradation kinetics of biodegradable scaffolds for tissue engineering. Biomaterials.2000;21:2443-2452.
[18] Lu L,Peter SJ,Lyman MD,et al.In vitro and in vivo degradation of porous poly(D,L-lactic-co-glycolic acid) foams. Biomaterials. 2000;21:1837-1845.
[19] Park S,Kim JH,Kim IH,et al.Evaluation of Poly (lactic-co-glycolic Acid) Plate and Screw System for Bone Fixation.J Craniofac Surg.2013;24(3):1021-1025.
[20] Patrascu JM,Krüger JP,Böss HG,et al.Polyglycolic acid-hyaluronan scaffolds loaded with bone marrow-derived mesenchymal stem cells show chondrogenic differentiation in vitro and cartilage repair in the rabbit model.J Biomed Mater Res B Appl Biomater.2013;101(7):1310-1320.
[21] Tanaka T,Hirose M,Kotobuki N,et al.Bone augmentation by bone marrow mesenchymal stem cells cultured in three-dimensional biodegradable polymer scaffolds.J Biomed Mater Res A.2009; 91(2):428-435.
[22] Theiss F,Apelt D,Brand B,et al.Biocompatibility and resorption of a brushite calcium phosphate cement.Biomaterials.2005; 26(21): 4383-4394.
[23] Matsuo A,Yamazaki Y,Takase C,et al.Osteogenic potential of cryopreserved human bone marrow–derived mesenchymal stem cells cultured with autologous serum. J Craniofac Surg. 2008;19:693-700.
[24] Shimakura Y,Yamzaki Y,Uchinuma E,et al.Experimental study on bone formation potential of cryopreserved human bone marrow mesenchymal cell/hydroxyapatite complex in the presence of recombinant human bone morphogenetic protein-2. J Craniofac Surg.2003;14:108-116.
[25] Yoshioka M,Tanimoto K,Tanne Y,et al.Bone regeneration in artificial jaw cleft by use of carbonated hydroxyapatite particles and mesenchymal stem cells derived from iliac bone. Int J Dent.2012;2012:352510.
[26] Tanimoto K,Sumi K,Yoshioka M,et al.Experimental Tooth Movement Into New Bone Area Regenerated by Use of Bone Marrow-Derived Mesenchymal Stem Cells.Cleft Palate Craniofac J. 2013.[Epub ahead of print]
[27] Wiltfang J,Merten HA,Schlegel KA,et al.Degradation characteristics of alpha and beta tri-calcium-phosphate (TCP) in minipigs.J Biomed Mater Res.2002;63(2):115-121.
[28] Yuan J,Cui L,Zhang WJ,et al.Repair of canine mandibular bone defects with bone marrow stromal cells and porous beta-tricalcium phosphate. Biomaterials. 2007;28(6): 1005-1013.
[29] Lee JH, Ryu MY, Baek HR,et al.Effects of porous beta-tricalcium phosphate-based ceramics used as an E. coli-derived rhBMP-2 carrier for bone regeneration. J Mater Sci Mater Med.2013;24(9): 2117-2127.
[30] Thomas MV,Puleo DA,Al-Sabbagh M.Calcium sulfate: a review. J Long Term Eff Med Implants 2005;15(6):599-607.
[31] Mao K,Cui F, Li J,et al.Preparation of combined β-TCP/α-CSH artificial bone graft and its performance in a spinal fusion model. J Biomater Appl.2012;27(1):37-45.
[32] Cao L, Duan PG, Wang HR,et al.Degradation and osteogenic potential of a novel poly(lactic acid)/nano-sized β-tricalcium phosphate scaffold.Int J Nanomedicine. 2012;7:5881-5888.
[33] Vozzi G,Corallo C,Carta S,et al.Collagen-gelatin-genipin- hydroxyapatite composite scaffolds colonized by human primary osteoblasts are suitable for bone tissue engineering applications: In vitro evidences. J Biomed Mater Res A.2014; 102(5):1415-1421.
[34] Chen L,Tang CY,Tsui CP,et al. Mechanical properties and in vitro evaluation of bioactivity and degradation of dexamethasone-releasing poly-d-l-lactide/nano-hydroxyapatite composite scaffolds. J Mech Behav Biomed Mater.2013;22: 41-50.
[35] Mouriño V,Cattalini JP,Roether JA,et al.Composite polymer-bioceramic scaffolds with drug delivery capability for bone tissue engineering. Expert Opin Drug Deliv. 2013;10(10): 1353-1365. |